Back | Next |
home / stock / fwbi / fwbi message board
Subject | By | Source | When |
---|---|---|---|
Where ? $5.20 just hit lmfao | stock1ace1 | investorshub | 01/23/2023 4:50:06 PM |
Im am worried about FDA rejection of IND | Sierra20 | investorshub | 01/20/2023 6:18:32 PM |
I SEE BREAKDOWN !! | power11 | investorshub | 01/20/2023 3:56:03 PM |
5.00$ break | stock1ace1 | investorshub | 01/20/2023 2:11:24 PM |
$4.90 premarket breaking out | stock1ace1 | investorshub | 01/20/2023 2:08:00 PM |
Get your 8 ball out what does it | stock1ace1 | investorshub | 01/20/2023 2:00:21 PM |
THE PRICE ACTION IN THE STOCKS SAYS TO | power11 | investorshub | 01/19/2023 6:19:57 PM |
Float getting locked up for fda news anyday now | stock1ace1 | investorshub | 01/19/2023 3:23:55 PM |
Fwbi $4.40 | stock1ace1 | investorshub | 01/19/2023 2:14:06 PM |
znewcar1: $FWBI 680% v1,1M c4.84 f5,8M H5.10 ML.43 YL.5 gapNheld4 | znewcar1 | investorshangout | 01/18/2023 10:47:59 PM |
The Company previously announced that it submitted the | stock1ace1 | investorshub | 01/18/2023 2:41:26 PM |
Pending FDA news 900k o/s ! | stock1ace1 | investorshub | 01/18/2023 2:41:20 PM |
Special meeting approved another R/S within a year. | kzivann | investorshub | 01/13/2023 3:34:14 PM |
You posted $9. If it doesn't hit | DollarSquad | investorshub | 01/04/2023 11:07:46 PM |
I WIN AGAIN. | THEMASTERS_SON | investorshub | 01/04/2023 10:07:15 PM |
$9 Target..expecting News next week! .87 | THEMASTERS_SON | investorshub | 12/31/2022 6:04:11 PM |
,,,,,,,30Days up.WE SHOULD SEE APPROVAL $NEXT WEEK. | THEMASTERS_SON | investorshub | 12/31/2022 1:08:30 AM |
FLOAT IS GONE!!!! $$$$$$$ COMETH | THEMASTERS_SON | investorshub | 12/30/2022 9:04:58 PM |
so your 7pm :) looks like a bad | all right all right | investorshub | 12/30/2022 8:14:16 PM |
Looks like baby $KAL A | THEMASTERS_SON | investorshub | 12/30/2022 12:48:55 PM |
News, Short Squeeze, Breakout and More Instantly...
First Wave BioPharma Inc. Company Name:
FWBI Stock Symbol:
NASDAQ Market:
Rebranding introduced as Company advances toward Phase 3 clinical trial with lead asset – latiglutenase for the treatment of celiac disease New Nasdaq ticker symbol is “ENTO” effective May 17, 2024 BOCA RATON, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Entero Ther...
BOCA RATON, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...